Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
ERHE showing some Greeen !
PTSC moving towards the Plus side, very nice
NGEN nice move and recent good news.
A better week to trade stocks one or 2 at a time and trade intraday as well. so far.
MDG List disappointments: medc, gtec, sphm, ptsc, crgo, vrdm.
Majority of the list in a correction phase.... dern. What looks good on a monday doesnt mean a stellar week. well they have their daily charts in line so maybe thursday and friday will be recovery days.. We shall see.
BMRN another Gapper. ( careful on these )...
(added to the MDG New Prospects List ). -DSDstock
REUTERS After the Bell - BioMarin shares jump on drug trial news
NEW YORK, March 15 (Reuters) - Shares of BioMarin
Pharmaceutical Inc. <BMRN.O> jumped more than 14 percent in
after-hours trading on Wednesday after the company said an
experimental oral molecule for the treatment of phenylketonuria
(PKU) met its goals in a late-stage clinical trial.
The stock surged $1.79 to $14.24 on the Inet electronic
brokerage system from a Nasdaq close of $12.45.
((Reporting by Ellis Mnyandu
editing by Jonathan Oatis
rm://ellis.mnyandu.reuters.com@reuters.net
Telephone: + 1 646-223-6085))
15Mar06 21:41 GMT
Symbols:
ch;BMR de;BM8 de;BM8F de;BM8S de;BM8X us;BMRN
Source RTRS Reuters News
Categories:
PLB cwazy gappuh !!
EGHT up 17% from previous day close
SLXA significant overnight climber
FNSR is moving premarket somewhat.
Novavax Receives Additional Government Funding for IV/AIDS Vaccine Research
MALVERN, Pa., March 16 /PRNewswire-FirstCall/ -- Novavax, Inc.
(Nasdaq: NVAX), announced approval today from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), of an additional commitment of approximately $1.0 million to fund the third year of a 4 1/2 year research program. Novavax is
developing a novel HIV/AIDS virus-like particle (VLP) vaccine as part of an NIH Integrated Preclinical/Clinical AIDS Vaccine Development Program comprised of scientists from the University of Alabama at Birmingham, Emory University, and Harvard Medical School. All three institutions are working with Novavax
in a collaboration to accelerate HIV/AIDS vaccine development.
Dr. Gale Smith, Vice President of Vaccine Development, explains, "We believe the only realistic solution to the global HIV/AIDS pandemic is an effective vaccine. Novavax is extremely pleased to be working with such an acknowledged group of world leaders in developing a novel HIV/AIDS vaccine.
Our research is based on our insect cell technology for the production of recombinant virus particles that mimic HIV-1, but without the risk of infection." According to Dr. Beatrice Hahn, one of the principal investigators at the University of Alabama at Birmingham, "Globally circulating strains of HIV-1 are extraordinarily variable, and this diversity poses a major obstacle to AIDS vaccine development. Currently, all candidate
vaccines are derived from contemporary HIV-1 isolates, often selected solely based on availability. With VLP vaccines produced by Novavax, we are now testing whether consensus immunogens can elicit broadly cross-reactive immune responses and thus protect against a wide range HIV-1."
In the first two years of the program, Novavax developed a process to manufacture HIV-1 VLPs from consensus sequences of the HIV-1 envelope glycoprotein, the principle target for virus neutralization. These synthetic genes were shown to be incorporated into particles that are structurally similar to HIV-1. Scientists at UAB, Emory, and Harvard discovered that the novel HIV/AIDS VLP vaccines induced a range of immune responses and antibodies in small animals and non-human primates that neutralized both laboratory strains and acute, contemporary HIV-1 isolates. The objectives for the team
during 2006 are to maximize efficiency of incorporation of the HIV-1 envelope glycoprotein into particles. Novavax then plans to begin preparations for human clinical trials of an improved HIV/AIDS VLP vaccine.
Copies of these filings may be obtained by contacting Novavax at 508 Lapp Road, Malvern, PA 19355 Tel 484-913-1200 or the SEC at www.sec.gov.
SOURCE Novavax, Inc.
Kathy Hamilton, Investor Relations of Novavax Inc., +1-484-913-1213,
khamilton@novavax.com
16Mar06 12:00 GMT
Symbols:
us;NVAX
Source PRN PR Newswire
NVAX nice one week chart...
AVNX moving greeen premarket.
MOVI Premarket Action towards the Greeeen !!!
One to watch WITM: OTCBB
Wits Basin Provides Updates on Gold Exploration Projects
MINNEAPOLIS--(Business Wire)--March 16, 2006--
Wits Basin Precious Minerals Inc. (OTCBB:WITM) announces
the following updates on its South African and Colorado gold
exploration projects.
FSC Project
Just recently, AfriOre Limited (TSX:AFO), our joint venture
partner and the operator at the FSC Witwatersrand Project (which
stands for "Free State Cape" project) recently met with members of our
management and board of directors and provided an update of the newly
available seismic data, including various geological documents that
are currently under review by AfriOre's team of experts. Their team
has identified the area for the next drilling target by utilizing last
year's drilling results and the follow up study of geophysics and
geophysical interpretation. Plans are underway to secure a drilling
rig as soon as available and place it into service. Wits Basin should
have updated information within the next six weeks.
Bates-Hunter
Plans for a site visit by Dr. Clyde Smith and members of his
consulting team have been scheduled. They will be selecting the
location for the underground drill station in order to test for the
multiple parallel veins believed to be present within the current mine
workings. The recently announced assay results, supplemented by the
samples currently being tested, will be used to develop a plan to
search for various multiple vein structures. The drilling equipment
has been readied and delivered to the mine site.
The surface drilling program is still being reviewed and drilling
contractors are being located and qualified. Wits Basin should have
updated information within the next four weeks regarding the
feasibility of a surface drilling program.
About Wits Basin Precious Minerals Inc.
We are a minerals exploration and development company holding
interests in three exploration projects and currently do not claim to
have any mineral reserves on any project. Our common stock trades on
the Over-the-Counter Bulletin Board under the symbol "WITM." To find
out more about Wits Basin Precious Minerals Inc. (OTCBB:WITM) visit
our website at www.witsbasin.com.
Forward-Looking Statements and Risk Factors
Certain statements contained in this press release are
forward-looking in nature and are based on the current beliefs and
assumptions of our management. Such statements are valid only as of
today, and we disclaim any obligation to update this information.
These statements are subject to known and unknown risks and
uncertainties that may cause actual future experience and results to
differ materially from the statements made. These statements are based
on our current beliefs and expectations as to such future outcomes.
The cost of exploration and exploitation can be extensive and
there is no assurance that we will have the resources necessary or the
financing available to pursue projects we currently hold interests.
The risks are numerous and detailed information regarding these risks
may be found in filings made by us with the Securities and Exchange
Commission, including our most recent annual report on Form 10-KSB,
quarterly reports on Form 10-QSB and reports on Form 8-K.
Wits Basin Precious Minerals Inc., Minneapolis
Stephen King, 612-490-3419
or
Vance White, 866-214-WITM(9486)
or
Redwood Consultants, LLC
Jens Dalsgaard, 415-884-0348
InvestorInfo@RedwoodConsultants.com
Copyright Business Wire 2006
16Mar06 12:16 GMT
Symbols:
us;WITM
Source BW Business Wire
Stockster has SEVI this morning: hmmm
OTC Picks has GGTS ( Gaming Stock ).
Hot (but just HOT) - (OTCBB:CTUM) CSMG Technologies Announces Successful Use of Tissue Welding/Bonding for Leak-Proof...
( From the MDG New Prospects List )dsdstock
CSMG Technologies Announces Successful Use of Tissue Welding/Bonding for Leak-Proof Lung Resection
CORPUS CHRISTI, Texas, March 15, 2006 (PRIMEZONE) -- CSMG Technologies, Inc. (OTCBB:CTUM) announced today that its patented tissue welding/bonding procedure has been successfully used for leak-proof lung resection.
Donald S. Robbins, President and CEO of CSMG, said, "Leak-proof lung procedures are almost impossible to conduct, but our technology welds, incises and provides a leak-proof seal and closure of the lung in less than a minute without charring, searing and necrosis or the need for drain tubes. This is one of many new advances in our platform patented tissue welding/bonding technology."
Photos of the leak-proof lung resection bonding/welding procedure can be viewed at ww.ctum.com/live_tissue_bonding.html or www.hawkassociates.com/csmg/company.htm.
CSMG owns the technology and exclusive world rights to the medical device for this procedure through Live Tissue Connect, Inc., a subsidiary corporation formed for the development and exploitation of the platform technology.
The tissue welding/bonding technology for repair and reconnection of tissue and hollow organs is smokeless, with little heat migration in the tissue. It results in no necrosis and is without the use of foreign matter or conventional
wound-closing devices, such as staples, sutures, glues or sealant. The procedures are almost bloodless. Unlike other tissue coagulation methods that tend to destroy tissue by charring, searing and necrosis, the CSMG-patented
technology bonds and reconnects incised tissue using a patented low-heat delivery method aimed at restoring the normal functions of the live organs and tissue. The technology leaves little or no scar visible to the naked eye.
CSMG Technologies maintains offices in Corpus Christi, Texas; Washington D.C.;
Atlanta, Ga.; and Kiev, Ukraine. For CSMG's stock quotes, visit www.otcbb.com.
For more information, visit www.ctum.com, e-mail publicrelations@ctum.com, or
contact Don Robbins at (361) 887-7546.
Additional information about CSMG can be found at www.ctum.com or e-mail publicrelations@ctum.com. An online investor kit containing CSMG press releases, SEC filings, current Level II price quotes, interactive Java, stock charts and other useful information for investors can be found at www.hawkassociates.com/csmg and www.hawkassociates.com/csmg/kit.htm.
Investors may contact Don Robbins or K. Bruce Jones, CSMG, at (361) 887-7546,
publicrelations@ctum.com, or Frank Hawkins or Julie Marshall, Hawk Associates,
at (305) 451-1888, info@hawkassociates.com.
-0-
CONTACT: CSMG Technologies, Inc.
Donald S. Robbins, President and CEO
(361) 887-7546
K. Bruce Jones
(770)955-0409
15Mar06 16:46 GMT
Symbols:
us;CTUM
Source PZM PrimeZone Media
LUKEWARM - ADVC: OTCBB Advanced Communications Reports Continued Strong Revenue Results For February; Reflects A 71% Growth in EBITDA Compared With The Same Period Last Year
(From the New Prospects MDG List ).dsdstock
NEW YORK--(Business Wire)--March 9, 2006--
Advanced Communications Technologies, Inc. (OTC Bulletin
Board: ADVC), a New York-based holding company that specializes in the
technology aftermarket service and supply chain known as reverse
logistics, announced today that it's electronic equipment repair
subsidiary Cyber-Test, Inc. generated $820,000 in revenue for the
month of February 2006 with EBITDA of $77,000 or 9.4% of revenue,
compared with $650,000 in revenue and $36,000 of EBITDA or 5.5% of
revenue for the same month last year, representing a 26.2% revenue
increase and a 71% growth in EBITDA.
Wayne Danson, president and CEO of Advanced Communications said,
"Cyber-Test continues to perform exceptionally well and attract new
business because of its program of service excellence in delivering
timely and cost-effective services to its customers." Danson added,
"Our business strategy remains in full force as we are in the process
of seeking target companies that complement our expansion plan of
providing an integrated life-cycle service for the consumer
electronics industry."
Danson closed with, "Our $10 million revenue projection for fiscal
2006 remains on target and we look forward to sharing our acquisition
progress with shareholders as soon as we are allowed under SEC
regulations."
Cyber-Test's ability to meet the consumer's demand and its
reputation for providing preeminent electronic repair and asset
recovery services is flourishing, as its customer base continues to
grow. For more information on Cyber-Test's services, visit their
website at http://www.equipfix.com.
About Advanced Communications Technologies
Advanced Communications Technologies is a New York-based public
holding company specializing in the technology aftermarket service and
supply chain, known as reverse logistics. Its wholly owned subsidiary
and principal operating unit, Encompass Group Affiliates, Inc.
acquires and operates businesses that provide computer and electronics
repair and end-of-lifecycle services and provides asset distribution
and recovery services. Encompass owns Cyber-Test, Inc., an electronic
equipment repair company based in Florida that provides board-level
repair of technical products to third-party warranty companies, OEMs,
national retailers and national office equipment dealers. Service
options include advance exchange, depot repair, call center support,
parts and warranty management for office equipment, fax machines,
printers, scanners, laptop computers, monitors, CPU towers, and
multi-function units including high-end consumer electronics such as
PDAs and digital cameras. For more information, visit
http://www.advancedcomtech.net, or Cyber-Test's website at
http://www.equipfix.com.
This release and oral statements made from time to time by the
company's representatives concerning the same subject matter may
contain "forward-looking statements" within the meaning of the Private
Securities Litigation Reform Act of 1995. These statements can be
identified by introductory words such as "expects," "plans,"
"intends," "should," "believes," "will," "estimates," "forecasts,"
"projects" or words of similar meaning, and by the fact that they do
not relate strictly to historical or current facts. Many factors may
cause actual results to differ from forward-looking statements,
including inaccurate assumptions and a broad variety of risks and
uncertainties, some of which are known and others of which are not.
Known risks and uncertainties include those identified from time to
time in the reports filed by the company with the Securities and
Exchange Commission, which should be considered together with any
forward-looking statement. No forward-looking statement is a guarantee
of future results or events, and one should avoid placing undue
reliance on such statements.
Advanced Communications Technologies, Inc.
Wayne Danson, 646-227-1600
Copyright Business Wire 2006
09Mar06 13:30 GMT
Symbols:
us;ADVC
Source BW Business Wire
"INSG is the main pick right now." - lancebps
Looking like a good call from todays news - DSDstock.
HOT HOT HOT - INSG : Nasdaq Insignia Solutions Provides Fourth Quarter 2005 Financial Update; Customer Base Expands To 23 Mobile Operator Customers in 2005 ( From the MDG New Prospects LIST ).
FREMONT, Calif.--(Business Wire)--March 15, 2006--
Insignia Solutions (Nasdaq:INSG) today provided an
update on its fourth quarter and twelve months ended December 31, 2005. The Company expects to report its complete financial results on March 31, 2006.
Total revenue for the fourth quarter of 2005 is estimated at
between $1.1 million - $1.2 million, compared to $8,000 in the same period in the prior year and $800,000 in the third quarter of 2005. During the recently completed fourth quarter, approximately 72% of revenue was from sales of the Device Management Server (DMS), 26% from sales of Open Management Client (OMC), and 2% from sales of Secure System Provisioning (SSP).
The operating loss for the fourth quarter of 2005 is estimated at between $1.2 million - $1.3 million, compared to a loss of $2.1 million in the same period of the prior year, and a loss of $1.4 million in the third quarter of 2005. Loss per share for the fourth quarter of 2005 is estimated at between $0.03 - $0.04 per share, compared to a loss of $0.06 per share in the same period of the prior year and a loss of $0.04 per share in the third quarter of 2005.
Total revenue for the twelve months ended December 31, 2005 is
estimated at between $3.1 million - $3.2 million, compared to $0.5 million in the same period of the prior year. Loss for the twelve months ended December 31, 2005 is estimated at between $6.6 million - $6.8 million or approximately $0.15 - $0.16 per share, compared to a loss of $7.1 million or $0.23 per share in the same period of the prior year. In the first quarter of 2005, $213,000 of pre-acquisition revenue from Mi4e was not included in Insignia's reported results.
The Company's cash and cash equivalents were approximately $1.2
million as of December 31, 2005, compared to $902,000 at December 31, 2004. Shareholders' equity at December 31, 2005 is estimated at $2.5 million compared to $1.3 million at December 31, 2004. At December 31, 2005, the Company had approximately 43 million ordinary shares issued and outstanding compared to 36 million ordinary shares at December 31, 2004.
Insignia Solutions
John Davis, 408-874-2600
or
Financial Dynamics
Quynh Nguyen or Jordan Goldstein, 415-439-4500
Copyright Business Wire 2006
15Mar06 22:25 GMT
Symbols:
de;IN8 us;INSG
Source BW Business Wire
GNOLF: OTCBB - Genoil's Technology GHU'TM' Patent Approved by United States Patent ( From the MDG New Prospects List ).
NEWS RELEASE TRANSMITTED BY CCNMATTHEWS
Genoil Inc.
March 15, 2006 - 06:00:14 ET
Genoil's Technology GHU'TM' Patent Approved by United States Patent
CALGARY, ALBERTA--(CCNMatthews - March 15, 2006) - Genoil Inc. (TSX VENTURE:GNO) (OTCBB:GNOLF) is pleased to announce that the United States Patent and Trademark Office has approved the patent of its innovative upgrading technology, the GHU (Genoil Hydroconversion Upgrader).
The GHU patent was officially issued on February 21, 2006 and it means a great step in the commercialization of the upgrader. Genoil is proud of offering this technology as an alternative to other upgrading process and as a solution to the existing problems of the oil and gas production and refinery industry.
The GHU uses hydrogen addition to convert heavy oil fractions into a lighter synthetic crude, with reduced sulphur and nitrogen contents that can be pipelined from the field without the need for mixing lighter oil or adding diluents and bring a higher price that the heavy crude with high sulphur content. The GHU process can not only increase the value of the oil, but also increase the volume output, while eliminating sulphur, nitrogen, metals and other contaminants from the oil, and helping to meet tight environmental regulations for clean transportation fuel. The GHU produces no coke in the
upgrading process unlike traditional upgrading schemes that use the coking technology to upgrade, and the heavy residue fraction left after upgrading is reused as a gasifier to product the required hydrogen to operate the process.
Genoil has been working since the filing of this patent on improvements in its process, and is planning additional patents to cover those improvements in the near future.
"We are very excited about our newly issued US patent and Genoil's outlook for the use of the GHU technology to help relieve the current crude supply restrictions and allow the heavier crude fractions to be upgraded into a more
useful synthetic crude which in turn will allow for increased production of motor fuels with reduced sulphur content. The world's oil supply is getting heavier every year and the GHU technology will allow producers to utilize their production of heavy crude, receive a high price for the upgraded crude
and assist in keeping up with the increasing demand to find more crude sources to meet the demand." said James Runyan, Genoil's Senior Vice President of Operations and Engineering in Alberta.
Genoil is a technology development company providing solutions to the oil and gas industry through the use of proprietary technologies. Genoil's shares are listed on the TSX Venture Exchange under the symbol GNO, as well as on the OTC
Bulletin Board under GNOLF.OB.
ADVISORY: Certain information regarding the company, including management's assessment of future plans and operations, may constitute forward-looking statements under applicable securities law and necessarily involve risks associated with oil and gas exploration, production, marketing and
transportation such as loss of market, volatility of prices, currency fluctuations, imprecision of reserve estimates, environmental risks, competition from other producers and ability to access sufficient capital from internal and external sources; as a consequence, actual results may differ materially from those anticipated. The company assumes no obligation to update the forward-looking statements or to update the reasons why actual results could differ from those contemplated by the forward-looking statements.
Statements included in this release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements involve a number of risks and uncertainties such as competitive factors, technological development, market demand, and the
company's ability to obtain new contracts and accurately estimate net revenues due to variability in size, scope and duration of projects, and internal issues in the sponsoring client. Further information on potential risk factors
that could affect the company's financial results can be found in the company's Reports filed with the Securities and Exchange Commission.
Genoil Inc. James Runyan Senior Vice President (780) 416-5590 Website:
www.genoil.net
The TSX Venture Exchange has neither approved nor disapproved of the
information contained herein.
15Mar06 11:00 GMT
Symbols:
ca;GNO de;GNG us;GNOL
Source CCN CCNMatthews
SEIB.OTCBB From the MDG New Prospects List:
S3 Investment Company Announces Major SINO UJE Supplier Orders for January
TEMECULA, Calif.--(Business Wire)--Feb. 16, 2006--
S3 Investment Company, Inc. (OTCBB:SEIH) today announced
that portfolio investment SINO UJE received multiple orders for Ulrich GmbH & Co. injector systems from Chinese hospitals and original equipment manufacturers (OEMs), including GE Medical Systems, Siemens and Philips, during the month of January 2006.
The Ulrich (www.ulrich-ulm.de/eng/start.html) is a world leader in the design and manufacture of injector systems used for medical imaging applications, such as CT and MRI equipment. SINO UJE is in the business of distributing high-tech medical and industrial products to markets throughout China. SINO UJE purchases products from Original Equipment Manufacturers (OEMs) in North America, Europe and Japan and re-sells the equipment to end users through its distribution network in China.
The addition of OEMs as customers has been an important milestone for SINO UJE, as half of all injector orders in China are placed through the CT or MRI original equipment manufacturers (OEM) directly. By receiving orders from major equipment manufacturers, SINO UJE has established a foothold in the half of the injector market not previously accessed through its distribution network in China. "We are pleased that SINO UJE has started the year so successfully, receiving these orders for Ulrich products and a number of other orders from suppliers in the SINO UJE network," stated S3 chief executive officer Jim Bickel. "We expect to announce some additional January milestones achieved by SINO UJE in the very near
future, as well as details of SINO UJE's partnership with GreCon and its expanding business in China."
"At the pace we are seeing from the first month of the 2006
calendar year, we expect that SINO UJE will outpace its 2005
performance and become an even more valuable asset for S3 and its shareholders," added Mr. Bickel.
To sign up to receive information by email directly from S3
Investment Company when new press releases, investor newsletters, SEC filings or other information is disclosed, please visit http://www.s3investments.com/ealert.asp.
Gemini Financial Communications for S3 Investment Co.
A. Beyer, 951-587-8072
investors@s3investments.com
Copyright Business Wire 2006
16Feb06 14:15 GMT
Symbols:
de;SDI us;SEIH
Source BW Business Wire
ERHE.OB - UPDATE 1-Nigeria, Sao Tome sign oil deal with ERHC, Sinopec ( from the New Prospects List ).
(Adds details, background)
By Camillus Eboh
ABUJA, March 15 (Reuters) - Nigeria and Sao Tome on
Wednesday signed a production sharing contract with a consortium
led by ERHC <ERHE.OB> and Sinopec <SNP.N><0386.HK> for one of
the deep-water oil exploration blocks they jointly administer.
Nigeria, Africa's top oil producer, and the tiny twin island
nation of Sao Tome and Principe, which has not yet started
producing oil, have a joint development zone in the Gulf of
Guinea, one of the world's most promising exploration areas.
The consortium led by little-known Houston-based ERHC and
Chinese energy giant Sinopec will pay a signature bonus of $71
million for block 2 in the joint development zone. The two firms
are the operators.
ERHC, which has been at the centre of controversies since it
gained stakes in all five exploration blocks awarded by Nigeria
and Sao Tome last May, brought in Sinopec as its partner for
block 2 after two previous partners pulled out.
China is among several Asian economic heavyweights vying
with the United States for West African oil in an effort to
secure supplies from outside the volatile Middle East.
Chinese, Indian and Korean firms have competed fiercely for
other Nigerian oil concessions.
Other stakeholders in block 2 include London-listed Equator
Exploration <EEL.L> and ONGC <ONGC.BO> of India, which together
have 15 percent. A & Hartman has 10 percent while Foby
Engineering and Momo Oil and Gas have 5 percent each.
DELAYS
The Nigeria-Sao Tome licensing round was repeatedly delayed
by arguments between the two countries and accusations of
corruption. After the blocks were finally awarded, the process
of negotiating contracts was also delayed for months, with
companies pulling out and new allegations of bribery.
U.S. firm Devon <DEV.N> ducked out of a partnership with
ERHC in block 2 last year. It was replaced by another U.S.
company, Pioneer Natural Resources Co. <PXD.N>, which pulled out
on Feb. 7 because of disagreements with ERHC.
In block 4, ERHC also lost its initial partner when Noble
Energy withdrew and was replaced by Canada-based Addax Petroleum
<AXC.TO>.
ERHC, listed in the United States but controlled by private
Nigerian firm Chrome, emerged as the big winner of the joint
development zone licensing round despite having little
exploration experience or financial means to carry out the work.
It was the only company to gain stakes in all five blocks
awarded last May. It was named operator, along with other
companies, in two of the blocks.
The Joint Development Authority says ERHC had been granted
preferential rights on stakes in the blocks in return for
exploration investment in Sao Tome in the 1990s, before the
joint development zone was set up.
Details of those investments have not been made public.
Late last year, the Sao Tome attorney-general said there
were indications that ERHC made improper payments to Sao Tome
officials. The company denies any wrongdoing.
Nigeria has dismissed the attorney-general's report as a
product of internal politics of Sao Tome, which holds elections
later this year and where political tensions have risen as the
country prepares to enter the world of big oil.
ca;AXC de;CHU gb;EEL gb;SNP hk;386 in;ONG us;EASA us;ERHE us;PXD us;SNP
Source RTRS Reuters News
Categories:
KSWJ - FASCINATING SUB-PENNY HERE !!!
Bullish Close of Trade 4 pm March 15, 2006.
You called it earlier, I was doubtful but PTSC pulled it off.
EMKR and MOVI should have been the fill ins today, oh well hindsight is 20/20.
AVNX doing fine thank you.
MOVI wowwwwwwwwwwwwwwwwwwwwwwww........
Nice.
MOVI Whats up with that ????
IIIN nice stock since January nice smooth riser.
IIIN since January the smoothest chart I have seen. WOW... Nice day today as well at 3.32 % increase so far.
BDGR looking pretty good.
INLD cranking a bit now.
ERHE ready for another short rally ?
LFWK carrying the major rally today.....
Bloodbath on the microcaps last 2 days.
OTCBB Top 100 is essentially minus 20% plus to minus averages, this is the worst day of trade in microcaps that I have seen in a while.
ONSC back in rally mode.
ERHE not a bad rally or set of rallies today.